| |
| |
|
| Insider
Information: |
Tyle Praveen |
| Relationship: |
EVP, R&D |
| City: |
Rochester |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
125,805 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$254,094 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
125,805 |
|
|
| Total
Value |
$254,094 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -10.4%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bausch & Lomb, Inc. |
BOL.04 |
Senior Vice President |
2007-10-26 |
0 |
2007-10-26 |
0 |
Premium* |
|
|
Kiora Pharmaceuticals |
KPRX |
Director |
2024-08-19 |
5,014 |
2015-05-01 |
0 |
Premium* |
|
|
Lexicon Pharmaceuticals Inc |
LXRX |
EVP, R&D |
2021-02-28 |
120,791 |
2018-02-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BOL.04 |
Bausch & Lomb, Inc. |
Vice President |
• – – |
2004-07-19 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
8,000 |
|
- |
|
| BOL.04 |
Bausch & Lomb, Inc. |
Vice President |
• – – |
2005-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
28,000 |
|
- |
|
| BOL.04 |
Bausch & Lomb, Inc. |
Senior Vice President |
• – – |
2007-10-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(45,324) |
0 |
0 |
- |
|
| BOL.04 |
Bausch & Lomb, Inc. |
Senior Vice President |
• – – |
2007-10-26 |
4 |
D |
$0.00 |
$0 |
I/I |
(452) |
0 |
0 |
- |
|
| BOL.04 |
Bausch & Lomb, Inc. |
Senior Vice President |
• – – |
2007-10-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,025 |
0 |
0 |
- |
|
| KPRX |
Kiora Pharmaceuticals |
Director |
– • – |
2015-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
11,893 |
11,893 |
0 |
- |
|
| KPRX |
Kiora Pharmaceuticals |
Director |
– • – |
2015-08-28 |
4 |
A |
$0.00 |
$0 |
D/D |
5,748 |
11,893 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, R&D |
• • – |
2018-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,990 |
2,990 |
0 |
- |
|
| KPRX |
Kiora Pharmaceuticals |
Director |
– • – |
2018-07-10 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
61,893 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, R&D |
• • – |
2019-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,717 |
14,979 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, R&D |
• • – |
2020-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
39,316 |
54,295 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, R&D |
• • – |
2020-04-22 |
4 |
A |
$0.00 |
$0 |
D/D |
19,893 |
74,188 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, R&D |
• • – |
2021-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
68,007 |
137,351 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, R&D |
• • – |
2020-04-22 |
4 |
D |
$1.96 |
$9,494 |
D/D |
(4,844) |
69,344 |
0 |
- |
|
| KPRX |
Kiora Pharmaceuticals |
Director |
– • – |
2024-08-19 |
4 |
B |
$3.96 |
$19,800 |
D/D |
5,000 |
5,014 |
2.39 |
% |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, R&D |
• • – |
2021-02-28 |
4 |
D |
$7.19 |
$119,066 |
D/D |
(16,560) |
120,791 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, R&D |
• • – |
2018-02-28 |
4 |
D |
$8.53 |
$6,210 |
D/D |
(728) |
2,262 |
0 |
- |
|
| BOL.04 |
Bausch & Lomb, Inc. |
Senior Vice President |
• – – |
2007-07-19 |
4 |
D |
$67.46 |
$78,793 |
D/D |
(1,168) |
27,268 |
0 |
- |
|
18 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
